Dengue fever has emerged as a major public health problem globally in the past three decades. A 13-year national surveillance data analysis was done to describe the epidemiology and its trend of dengue disease in Oman reported between 2001 and 2013. Laboratory-confirmed dengue virus infections reported were studied retrospectively during the study period. A total of 64 laboratory confirmed cases were reported. All the patients contracted the disease during their visit to South-East Asian countries, hence classified as imported cases. The majority of the cases were reported in the year 2012 (23.4%). The most important clinical characteristics were fever (90.6%), myalgia (35.9%) and rash/petechial rash (20.3%). Thrombocytopenia was seen in 31.2% of the study subjects. The mortality was nearly 4.6% and all other patients made a full recovery. The most effective measure for travellers is taking precautions to avoid mosquito bites.
San MartínJLBrathwaiteOZambranoB. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality. Am J Trop Med Hyg2010; 82: 128–135.
Ferreira GLC. Global dengue epidemiology trends. Rev Inst Med Trop São Paulo 2012; 54 (Suppl. 18): S5–S6.
5.
RekolHPhilippeBAnneC. National dengue surveillance in Cambodia 1980–2008: epidemiological and virological trends and the impact of vector control. Bull World Health Organ2010; 88: 650–657.
6.
Ministry of Health, Oman. Emerging Infectious Diseases - Part 1. Community Health and Disease Newsletter 2010; 19: 1–5. Available at: http://www.cdscoman.org/ uploads/cdscoman/Newsletter%2019-4.pdf (accessed 15 December 2013).
7.
World Health Organization. Dengue: call for urgent interventions for a rapidly expanding emerging disease.Regional Committee for the Eastern Mediterranean, Technical Paper. Geneva: WHO; 2011. Available at http://applications.emro.who.int/docs/RC_technical_ papers 2011_3_14217.pdf (accessed on 20 December 2013).
Ministry of Health, Oman. Communicable disease surveillance and control. A standard operating procedures manual. 2nd edn. Muscat: Ministry of Health; 2005. Available at: http://www.cdscoman.org/uploads/cdscoman/CDS%20Manual.pdf (accessed 15 December 2013).
OoiEEGohKTGublerDJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis2006; 12: 887–893.
15.
TengAKSinghS. Epidemiology and new initiatives in the prevention and control of dengue in Malaysia. Dengue Bull2001; 25: 7–12.
16.
KongsomboonKSinghasivanonPKaewkungwalJ. Temporal trends of dengue fever/dengue hemorrhagic fever in Bangkok, Thailand from 1981 to 2000: an age-period-cohort analysis. Southeast Asian J Trop Med Public Health2004; 35: 913–917.
17.
ThaiKTNagelkerkeNPhuongHL. Geographical heterogeneity of dengue transmission in two villages in southern Vietnam. Epidemiol Infect2010; 138: 585–591.
18.
JelinekT. Dengue fever in international travelers. Clin Infect Dis2000; 1: 144–147.
19.
GublerDJClarkGG. Dengue/Dengue Hemorrhagic Fever: The Emergence of a Global Health Problem. Emerg Infect Dis1995; 1: 55–57.
20.
World Health Organization. Report on Global Surveillance of Epidemic-prone Infectious Diseases - Dengue and dengue haemorrhagic fever. Global Alert and Response, Description of the data. Geneva: WHO; 2001. Available at: http://www.who.int/csr/resources/ publications/dengue/CSR_ISR_2000_1/en/index3.html (accessed on 2 January 2014).
21.
GuyBBarrereBMalinowskiCSavilleMTeyssouRLangJ. From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine. Vaccine2011; 29: 7229–7241.
